Cargando…

The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk

Framingham risk score (FRS), systematic coronary risk evaluation (SCORE), the 10-year atherosclerotic cardiovascular disease risk algorithm (ASCVD), and their modified risk scores are the most common cardiovascular risk scores. The aim of this case–control study was to evaluate the performance of ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Li, Luo, Qiang, Hu, Yinlan, Yan, Shuangshuang, Yang, Xiaoqian, Zhang, Yiwen, Xiong, Feng, Wang, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193404/
https://www.ncbi.nlm.nih.gov/pubmed/37215054
http://dx.doi.org/10.1515/med-2023-0703
_version_ 1785043830341369856
author Qin, Li
Luo, Qiang
Hu, Yinlan
Yan, Shuangshuang
Yang, Xiaoqian
Zhang, Yiwen
Xiong, Feng
Wang, Han
author_facet Qin, Li
Luo, Qiang
Hu, Yinlan
Yan, Shuangshuang
Yang, Xiaoqian
Zhang, Yiwen
Xiong, Feng
Wang, Han
author_sort Qin, Li
collection PubMed
description Framingham risk score (FRS), systematic coronary risk evaluation (SCORE), the 10-year atherosclerotic cardiovascular disease risk algorithm (ASCVD), and their modified risk scores are the most common cardiovascular risk scores. The aim of this case–control study was to evaluate the performance of cardiovascular risk scores in detecting carotid subclinical atherosclerosis (SCA) in patients with idiopathic inflammatory myopathies (IIMs). A total of 123 IIMs patients (71.5% female, mean age 50 ± 14 years) and 123 age- and gender-matched healthy controls were included in this study. Carotid SCA was more prevalent in IIMs patients compared with controls (77.2 vs 50.4%, P < 0.001). Moreover, patients with carotid SCA+ had older age, and all risk scores were significantly higher in IIMs patients with SCA+ compared to subjects with SCA− (all P < 0.001). According to FRS, SCORE, and ASCVD risk scores, 77.9, 96.8, and 66.7% patients with SCA+ were classified as low risk category, respectively. The modified scores also demonstrated a modest improvement in sensitivity. Notably, by adopting the optimal cutoff values, these risk scores had good discrimination on patients with SCA+, with area under curves of 0.802–0.893. In conclusion, all cardiovascular risk scores had a poor performance in identifying IIMs patients at high cardiovascular risk.
format Online
Article
Text
id pubmed-10193404
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-101934042023-05-19 The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk Qin, Li Luo, Qiang Hu, Yinlan Yan, Shuangshuang Yang, Xiaoqian Zhang, Yiwen Xiong, Feng Wang, Han Open Med (Wars) Research Article Framingham risk score (FRS), systematic coronary risk evaluation (SCORE), the 10-year atherosclerotic cardiovascular disease risk algorithm (ASCVD), and their modified risk scores are the most common cardiovascular risk scores. The aim of this case–control study was to evaluate the performance of cardiovascular risk scores in detecting carotid subclinical atherosclerosis (SCA) in patients with idiopathic inflammatory myopathies (IIMs). A total of 123 IIMs patients (71.5% female, mean age 50 ± 14 years) and 123 age- and gender-matched healthy controls were included in this study. Carotid SCA was more prevalent in IIMs patients compared with controls (77.2 vs 50.4%, P < 0.001). Moreover, patients with carotid SCA+ had older age, and all risk scores were significantly higher in IIMs patients with SCA+ compared to subjects with SCA− (all P < 0.001). According to FRS, SCORE, and ASCVD risk scores, 77.9, 96.8, and 66.7% patients with SCA+ were classified as low risk category, respectively. The modified scores also demonstrated a modest improvement in sensitivity. Notably, by adopting the optimal cutoff values, these risk scores had good discrimination on patients with SCA+, with area under curves of 0.802–0.893. In conclusion, all cardiovascular risk scores had a poor performance in identifying IIMs patients at high cardiovascular risk. De Gruyter 2023-05-17 /pmc/articles/PMC10193404/ /pubmed/37215054 http://dx.doi.org/10.1515/med-2023-0703 Text en © 2023 the author(s), published by De Gruyter https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Research Article
Qin, Li
Luo, Qiang
Hu, Yinlan
Yan, Shuangshuang
Yang, Xiaoqian
Zhang, Yiwen
Xiong, Feng
Wang, Han
The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
title The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
title_full The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
title_fullStr The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
title_full_unstemmed The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
title_short The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
title_sort poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193404/
https://www.ncbi.nlm.nih.gov/pubmed/37215054
http://dx.doi.org/10.1515/med-2023-0703
work_keys_str_mv AT qinli thepoorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT luoqiang thepoorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT huyinlan thepoorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT yanshuangshuang thepoorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT yangxiaoqian thepoorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT zhangyiwen thepoorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT xiongfeng thepoorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT wanghan thepoorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT qinli poorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT luoqiang poorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT huyinlan poorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT yanshuangshuang poorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT yangxiaoqian poorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT zhangyiwen poorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT xiongfeng poorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk
AT wanghan poorperformanceofcardiovascularriskscoresinidentifyingpatientswithidiopathicinflammatorymyopathiesathighcardiovascularrisk